PAG
YARW

Private Advisor Group’s Yarrow Bioscience YARW Stock Holding History

Private Advisor Group’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed -$28K – 1983
2020
Q4 		$28K Hold
5
– – ﹤0.01% 1738
2020
Q3 		$30K Hold
5
– – ﹤0.01% 1530
2020
Q2 		$31K Buy
+5
New +$33.9K ﹤0.01% 2346

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Private Advisor Group's YARW Position: Q1 2021 in Review

Private Advisor Group sold out of Yarrow Bioscience (YARW) in Q1 2021, closing a stake of 5 shares — an estimated $28K sold.

Private Advisor Group first reported a position in YARW in Q2 2020 and held it in 3 quarters. The position peaked at $31K in Q2 2020. 81 funds tracked by Wall St. Rank hold YARW as of Q1 2021.

  • Private Advisor Group reported no remaining Yarrow Bioscience position as of Q1 2021 after selling out during the quarter.
  • Private Advisor Group sold 5 Yarrow Bioscience shares in Q1 2021, an estimated $28K.
  • Private Advisor Group first reported a position in Yarrow Bioscience in Q2 2020 and held it in 3 quarters.
  • Private Advisor Group's Yarrow Bioscience position peaked at $31K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2021.

Based on Private Advisor Group's 13F filing for Q1 2021, filed 22 Apr 2021.